EZH2通过STAT3路径激活促进多发性骨髓瘤的进展
Yanyu Wang1, Jing Tian1, Dan Huang1
1Department of Oncology and Hematology, Leshan People's Hospital, 614000 Leshan, Sichuan, China.
Discovery medicine
|April 26, 2024
概括
增强性胆固醇同源2 (EZH2) 通过激活转录3 (STAT3) 途径的信号传感器和激活器来促进多发性骨髓瘤的进展. 准EZH2和STAT3可能为多发性骨髓瘤治疗提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 多发性髓瘤 (MM) 是一种骨髓恶性瘤,其特征是克隆性血细胞增殖.
- 增强器的凝血同类2 (EZH2) 和信号传感器和转录3 (STAT3) 途径的激活器都涉及到各种恶性瘤.
研究的目的:
- 调查EZH2在多发性骨髓瘤 (MM) 进展中的作用.
- 为了阐明STAT3信号通路在EZH2-介导的MM病原发生过程中的参与.
- 确定MM的潜在治疗点.
主要方法:
- 定量实时PCR和西部抹黑,以评估MM细胞系中的EZH2表达.
- 在体外操纵EZH2和STAT3激活,使用转染,胆固醇和静态.
- 功能性检测包括殖民地形成,通井迁移和流动细胞计,以评估细胞增殖,迁移和细胞亡.
主要成果:
- 在mRNA和蛋白质水平上,EZH2在多个MM细胞系中显著过度表达.
- 增加EZH2表达增强了MM细胞的增殖和迁移,同时抑制了细胞亡.
- 这些效应被STAT3抑制逆转,并被STAT3激活模仿,表明EZH2通过STAT3途径起作用.
结论:
- EZH2通过激活STAT3途径促进多发性骨髓瘤的进展.
- 无论是EZH2和STAT3通路,都代表了多发性骨髓瘤治疗的有前途的治疗点.
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


